Bayer Pharma AG - Thu Jun 20 3:45:11 CEST 2013

Ultrasound (US)

MRI of the liver

Over the past few years, MRI of the liver has progressed significantly. MRI allows acquisition of images with excellent anatomical detail, high soft tissue contrast and largely free of artefacts secondary to respiratory motion. Fast sequences have reduced image acquisition time, thereby improving patient acceptance. New volumetric sequences have enabled three-dimensional serial dynamic imaging of the liver with high spatial and temporal resolution (Martin et al., 2005).

Unenhanced MR image (T1-weighted). Courtesy of Dr. Kühn, Germany
Unenhanced MR image (T1-weighted). Courtesy of Dr. Kühn, Germany
Unenhanced MR image (T2-weighted). Courtesy of Dr. Kühn, Germany
Unenhanced MR image (T2-weighted). Courtesy of Dr. Kühn, Germany

So called T1-weighted (scan-mode/water appears dark and fat bright) images allow thin-section imaging of the entire liver during a single suspended respiration. Volumetric three-dimensional sequencing enables improved detection, localization, and characterization of small lesions.

So called T2-weighted (scan-mode/water appears bright and fat grey) images are usually obtained through breathing-averaged or respiratory-triggered sequences with fat saturation (attenuation of the fat-signal). After the acquisition of unenhanced images, contrast-enhanced sequences are almost routinely obtained.

Benefits Drawbacks
  • Highest diagnostic accuracy
  • No radiation exposure
  • Excellent multiplanar imaging possibilities
  • Possibility to combine MR angiography/MR cholangiography sequences
  • Contrast media with a favorable safety profile available
  • Contrast media with a favorable safety profile available
  • Initial Primovist® MRI scan can lead to changes in therapy management
  • More time consuming than CT
  • Higher initial imaging cost in comparison to CT
Primovist

Search

Liver MRI with Primovist®

Typical T1-weighted MR liver image

High diagnostic accuracy due to liver-specific contrast media

Benign lesion

After Primovist® injection, T1-weighted sequence, liver-specific phase (after 20 min): The lesion is hypointense compared to the surrounding liver parenchyma

Cavernous hemangioma is the most common benign tumor of the liver

http://www.liver-imaging.com/scripts/pages/en/liver_imaging/magnet_resonance_imaging_mri/index.php
Copyright © Bayer Pharma AG